0001104659-17-070968.txt : 20171129 0001104659-17-070968.hdr.sgml : 20171129 20171129161712 ACCESSION NUMBER: 0001104659-17-070968 CONFORMED SUBMISSION TYPE: 8-A12B/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20171129 DATE AS OF CHANGE: 20171129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iKang Healthcare Group, Inc. CENTRAL INDEX KEY: 0001524190 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 000000000 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-A12B/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36403 FILM NUMBER: 171228520 BUSINESS ADDRESS: STREET 1: B-6F, SHIMAO TOWER STREET 2: 92A JIANGUO ROAD, CHAOYANG DISTRICT CITY: Beijing STATE: F4 ZIP: 100022 BUSINESS PHONE: 86 10-5320-6688 MAIL ADDRESS: STREET 1: B-6F, SHIMAO TOWER STREET 2: 92A JIANGUO ROAD, CHAOYANG DISTRICT CITY: Beijing STATE: F4 ZIP: 100022 FORMER COMPANY: FORMER CONFORMED NAME: iKang Guobin Healthcare Group, Inc. DATE OF NAME CHANGE: 20131129 FORMER COMPANY: FORMER CONFORMED NAME: China iKang Healthcare, Inc. DATE OF NAME CHANGE: 20110624 8-A12B/A 1 a17-27699_18a12ba.htm 8-A12B/A

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A/A

 

Amendment No. 2

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

 

iKang Healthcare Group, Inc.

(Exact name of registrant as specified in its charter)

 

Cayman Islands

 

Not Applicable

(State of incorporation or organization)

 

(IRS Employer
Identification No.)

 

B-6F, Shimao Tower

92A Jianguo Road
Chaoyang District, Beijing 100022

People’s Republic of China

(Address of principal executive offices)

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. o

 

Securities Act registration statement file number to which this form relates:

 

(if applicable)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class
to be so registered

 

Name of each exchange on
which each class is to be registered

 

 

 

Stock Purchase Rights

 

NASDAQ Stock Market

 

Securities to be registered pursuant to Section 12(g) of the Act:

 

None.

(Title of Class)

 

 

 


 

EXPLANATORY NOTE

 

This Amendment No. 2 to Form 8-A amends and supplements the Registration Statement on Form 8-A filed by iKang Healthcare Group, Inc., a company incorporated under the laws of the Cayman Islands (the “Company”), with the Securities and Exchange Commission (the “SEC”) on December 3, 2015, as amended by the Amendment No. 1 to Form 8-A filed by the Company with the SEC on November 30, 2016 (including the exhibits thereto, the “Form 8-A”). Capitalized terms used without definition herein shall have the meaning set forth in the Rights Agreement, dated as of December 2, 2015 (the “Original Rights Agreement”), between the Company and American Stock Transfer & Trust Company, L.L.C., as Rights Agent (the “Rights Agent”), as it was amended by the Amendment No. 1 to Rights Agreement, dated as of November 28, 2016 (the “Amendment No. 1”), and the subsequent Amendment No. 2 to Rights Agreement, dated as of November 29, 2017 (the “Amendment No. 2” and, together with the Original Rights Agreement and the Amendment No. 1, the “Rights Agreement”).

 

Item 1.                            Description of Registrant’s Securities to be Registered.

 

Item 1 of the Form 8-A is amended and supplemented by adding the following:

 

On November 29, 2017, the Company and the Rights Agent entered into the Amendment No. 2 to extend the expiration date of the Rights Agreement and the rights contained therein for one year to December 2, 2018.

 

The foregoing summary of Amendment No. 2 does not purport to be complete and is qualified in its entirety by reference to (i) the Original Rights Agreement, which was filed as Exhibit 4.1 to the Current Report on Form 6-K filed with the SEC on December 3, 2015, (ii) the Amendment No. 1, which was filed as Exhibit 4.1 to the Current Report on Form 6-K filed with the SEC on November 30, 2016, and (iii) the Amendment No. 2, which was filed as Exhibit 4.1 to the Current Report on Form 6-K filed with the SEC on November 29, 2017, each of which is incorporated herein by reference.

 

Item 2.                            Exhibits.

 

Exhibit No.

 

Description

4.1

 

Rights Agreement, dated as of December 2, 2015, between iKang Healthcare Group, Inc. and American Stock Transfer & Trust Company, L.L.C., as Rights Agent (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 6-K, filed on December 3, 2015).

 

 

 

4.2

 

Amendment No. 1 to Rights Agreement, dated as of November 28, 2016, between iKang Healthcare Group, Inc. and American Stock Transfer & Trust Company, L.L.C., as Rights Agent (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 6-K, filed on November 30, 2016).

 

 

 

4.3

 

Amendment No. 2 to Rights Agreement, dated as of November 29, 2017, between iKang Healthcare Group, Inc. and American Stock Transfer & Trust Company, L.L.C., as Rights Agent (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 6-K, filed on November 29, 2017).

 

2


 

SIGNATURE

 

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

IKANG HEALTHCARE GROUP, INC.

Date: November 29, 2017

 

 

 

By

/s/ Yang Chen

 

 

Name: Yang Chen

 

 

Title: Chief Financial Officer

 

 

 

 

 

 

 

3